141 lines
No EOL
7.1 KiB
HTML
141 lines
No EOL
7.1 KiB
HTML
<!-- Changed ON 09/24/2024 -->
|
|
<!-- Google Tag Manager -->
|
|
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
|
|
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
|
|
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
|
|
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
|
|
})(window,document,'script','dataLayer','GTM-T2DH393N');</script>
|
|
<!-- End Google Tag Manager -->
|
|
|
|
|
|
|
|
|
|
|
|
<HTML lang="en-US">
|
|
|
|
<!-- From NoticeTemplate.txt -->
|
|
|
|
|
|
|
|
|
|
<HEAD>
|
|
|
|
|
|
<TITLE>NOT-OD-19-106: Notice of the Publication of Revised NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules</TITLE>
|
|
|
|
|
|
<META NAME="description" CONTENT="NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Notice of the Publication of Revised NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules NOT-OD-19-106. NIH">
|
|
<META NAME="Keywords" CONTENT="NOT-OD-19-106: Notice of the Publication of Revised NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules">
|
|
<meta name="viewport" content="width=device-width, initial-scale=1.0">
|
|
<link href="../guide_styles/css/bootstrap.min.css" rel="stylesheet" media="screen">
|
|
<link href="../guide_styles/css/style.css" rel="stylesheet" media="screen">
|
|
<link href="../guide_styles/css/FOAM_Style.css" rel="stylesheet">
|
|
|
|
|
|
|
|
</HEAD>
|
|
|
|
<BODY>
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<div class="container">
|
|
<div class="row">
|
|
<div class="col-xs-12">
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<span class="title">Notice of the Publication of Revised NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules</span>
|
|
|
|
<hr noshade>
|
|
|
|
<p><span class="heading3">Notice Number:</span>
|
|
<span class="title">NOT-OD-19-106</span></p>
|
|
|
|
<p><span class="heading3">Key Dates</span><br>
|
|
<strong>Release Date: </strong>April 25, 2019</p>
|
|
<span class="heading3">Related Announcements</span><br>
|
|
<p><a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-218.html" target="_blank">NOT-OD-18-218</a><br><a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-022.html" target="_blank">NOT-OD-19-022</a></p>
|
|
<p><span class="heading3">Issued by</span><br>
|
|
OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH (<a href="https://public.era.nih.gov/foa/docTemplates/2813/exportDocument/html/NOT-OD-19-106.era?tracking=true" target="_blank">OD</a>)</p>
|
|
<p class="heading2">Purpose</p>
|
|
<p>On August 16, 2018, the <a href="https://www.nih.gov/about-nih/who-we-are/nih-director/statements/statement-modernizing-human-gene-therapy-oversight" target="_blank">NIH Director issued a statement</a> describing a proposal to streamline the federal framework for oversight of gene therapy. This proposal, which was developed in conjunction with the Food and Drug Administration, included amending the <em>NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) </em>to eliminate duplicative review and reporting requirements for human gene transfer protocols. The statement also describes NIH’s effort to refocus the role of the NIH Recombinant DNA Advisory Committee (RAC) to be closer to its original mandate a transparent forum for science, safety, and ethics of emerging biotechnologies. After a 60-day public comment period, the <em>NIH Guidelines</em> have been updated to reflect these changes and the RAC has been renamed the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC).</p>
|
|
<p>It is important to note that while NIH is streamlining individual protocol reporting requirements, robust oversight over gene therapy trials will continue as Federal and local oversight (e.g., FDA, Institutional Review Boards, Institutional Biosafety Committees) must continue to review and approve these trials before any research with human participants can be initiated.</p>
|
|
<p>More information about the final revisions can be found in the <a href="https://www.federalregister.gov/documents/2019/04/26/2019-08462/final-action-under-the-nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid">Federal Register</a>. The revisions described in the Federal Register are effective immediately. The complete version of the amended <em>NIH Guidelines</em> can be found at: <a href="https://osp.od.nih.gov/biotechnology/nih-guidelines/" target="_blank">https://osp.od.nih.gov/biotechnology/nih-guidelines/</a></p>
|
|
<p class="heading2">Inquiries</p>
|
|
<p>Please direct inquiries about this Notice to:</p>
|
|
<p>National Institutes of Health<br>
|
|
Office of Science Policy<br>
|
|
<a href="/cdn-cgi/l/email-protection#40132329252e2325102f2c292339002f246e2e29286e272f36"><span class="__cf_email__" data-cfemail="8ddeeee4e8e3eee8dde2e1e4eef4cde2e9a3e3e4e5a3eae2fb">[email protected]</span></a></p>
|
|
<p> </p>
|
|
|
|
|
|
|
|
|
|
|
|
</div>
|
|
</div>
|
|
|
|
|
|
<div class="row">
|
|
<div class="col-xs-12">
|
|
<P>
|
|
<HR>
|
|
<A HREF="/grants/guide/WeeklyIndex.cfm?04-26-19">Weekly TOC for this Announcement</A><br>
|
|
<A HREF="/grants/guide/index.html">NIH Funding Opportunities and Notices</A>
|
|
<hr>
|
|
</div>
|
|
</div>
|
|
<link rel="stylesheet" type="text/css" media="print" href="css/notices_print.css " />
|
|
|
|
|
|
|
|
|
|
|
|
<div class="row">
|
|
<div class="footer">
|
|
|
|
<div class="col-sm-4"> <a href="/grants/oer.htm"><img src="/images7/nih-oer-logo.jpg" alt="NIH Office of Extramural Research Logo" usemap="#Map2" border="0"></a>
|
|
<map name="Map2" id="Map2">
|
|
<area shape="rect" coords="89,17,359,39" href="http://www.nih.gov" />
|
|
<area shape="rect" coords="91,39,286,58" href="http://grants.nih.gov/grants/oer.htm" />
|
|
<area shape="rect" coords="3,5,78,55" href="http://grants.nih.gov/grants/oer.htm" />
|
|
</map>
|
|
</div>
|
|
<div class="col-sm-4">
|
|
<div style="float:left; padding: 5 5 5 70"> <a href="https://www.hhs.gov/"><img src="/images7/dhhs_sm.gif" width="36" height="37" border="0" alt="Department of Health and Human Services (HHS) - Home Page" long desc="Logo, circular in shape, depicting an American eagle in-flight with stylized profiles of human faces appearing on the trailing edge of the wings. The perimeter of the logo is encircled with the words 'Department of Health and Human Services U S A'"></a></div>
|
|
<div style="padding: 5 5 5 5;">Department of Health<br>
|
|
and Human Services (HHS)</div>
|
|
</div>
|
|
<div class="col-sm-4">
|
|
<div style="padding: 5 5 5 0" align="center"> <a href="https://www.usa.gov/"><img src="/images7/USA_Gov_logo.gif" border="0" alt="USA.gov - Government Made Easy" long desc="Logo,- the words 'USA.gov - Government Made Easy' with single streaking star above the logo"></a> </div>
|
|
</div>
|
|
</div>
|
|
</div>
|
|
|
|
|
|
<div class="row">
|
|
<div class="footer">
|
|
<div class="col-xs-12" align="center" style="padding: 20 5 5 5"> <span style="color:#6E6E6E; font-size:1.0em; font-family: 'Trebuchet MS', Arial, Helvetica, sans-serif">NIH... Turning Discovery Into Health<sup>®</sup></span> </div>
|
|
</div>
|
|
</div>
|
|
|
|
|
|
<div class="row">
|
|
<div class="footer">
|
|
<div class="col-xs-12" align="center">
|
|
|
|
</div>
|
|
</div>
|
|
</div>
|
|
|
|
</div>
|
|
|
|
<script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></BODY>
|
|
</HTML> |